Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic


Three life science companies unveiled Series B rounds of funding Thursday, early Christmas gifts that top $219 million combined. Along with Verge Genomics, the other companies that raised new capital are Tasso and Brainomix.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.